228 related articles for article (PubMed ID: 20550710)
1. The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.
Rokicki J; Das PM; Giltnane JM; Wansbury O; Rimm DL; Howard BA; Jones FE
Mol Cancer; 2010 Jun; 9():150. PubMed ID: 20550710
[TBL] [Abstract][Full Text] [Related]
2. HER4 selectively coregulates estrogen stimulated genes associated with breast tumor cell proliferation.
Han W; Jones FE
Biochem Biophys Res Commun; 2014 Jan; 443(2):458-63. PubMed ID: 24333426
[TBL] [Abstract][Full Text] [Related]
3. HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer.
Jones FE
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):247-58. PubMed ID: 18473151
[TBL] [Abstract][Full Text] [Related]
4. The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis.
Naresh A; Thor AD; Edgerton SM; Torkko KC; Kumar R; Jones FE
Cancer Res; 2008 Aug; 68(15):6387-95. PubMed ID: 18676864
[TBL] [Abstract][Full Text] [Related]
5. Direct coupling of the HER4 intracellular domain (4ICD) and STAT5A signaling is required to induce mammary epithelial cell differentiation.
Han W; Sfondouris ME; Jones FE
Biochem Biophys Rep; 2016 Sep; 7():323-327. PubMed ID: 28955922
[TBL] [Abstract][Full Text] [Related]
6. ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors.
Hertz DL; Henry NL; Kidwell KM; Thomas D; Goddard A; Azzouz F; Speth K; Li L; Banerjee M; Thibert JN; Kleer CG; Stearns V; Hayes DF; Skaar TC; Rae JM
Physiol Genomics; 2016 Sep; 48(9):688-98. PubMed ID: 27542969
[TBL] [Abstract][Full Text] [Related]
7. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells.
Zhu Y; Sullivan LL; Nair SS; Williams CC; Pandey AK; Marrero L; Vadlamudi RK; Jones FE
Cancer Res; 2006 Aug; 66(16):7991-8. PubMed ID: 16912174
[TBL] [Abstract][Full Text] [Related]
8. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.
Nakles RE; Shiffert MT; Díaz-Cruz ES; Cabrera MC; Alotaiby M; Miermont AM; Riegel AT; Furth PA
Mol Endocrinol; 2011 Apr; 25(4):549-63. PubMed ID: 21292825
[TBL] [Abstract][Full Text] [Related]
9. Subcellular localization of the HER4 intracellular domain, 4ICD, identifies distinct prognostic outcomes for breast cancer patients.
Thor AD; Edgerton SM; Jones FE
Am J Pathol; 2009 Nov; 175(5):1802-9. PubMed ID: 19808643
[TBL] [Abstract][Full Text] [Related]
10. Lapatinib restores hormone sensitivity with differential effects on estrogen receptor signaling in cell models of human epidermal growth factor receptor 2-negative breast cancer with acquired endocrine resistance.
Leary AF; Drury S; Detre S; Pancholi S; Lykkesfeldt AE; Martin LA; Dowsett M; Johnston SR
Clin Cancer Res; 2010 Mar; 16(5):1486-97. PubMed ID: 20179226
[TBL] [Abstract][Full Text] [Related]
11. The expression of estrogen, prolactin, and progesterone receptors in mammary gland and liver of female rats during pregnancy and early postpartum: regulation by thyroid hormones.
Varas SM; Jahn GA
Endocr Res; 2005; 31(4):357-70. PubMed ID: 16433254
[TBL] [Abstract][Full Text] [Related]
12. Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.
Herynk MH; Lewis MT; Hopp TA; Medina D; Corona-Rodriguez A; Cui Y; Beyer AR; Fuqua SA
Oncogene; 2009 Sep; 28(36):3177-87. PubMed ID: 19561644
[TBL] [Abstract][Full Text] [Related]
13. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of ERα and ERβ in normal and neoplastic development in the mouse mammary gland.
Mehta RG; Hawthorne M; Mehta RR; Torres KE; Peng X; McCormick DL; Kopelovich L
PLoS One; 2014; 9(11):e113175. PubMed ID: 25405629
[TBL] [Abstract][Full Text] [Related]
15. Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells.
Won Jeong K; Chodankar R; Purcell DJ; Bittencourt D; Stallcup MR
Mol Endocrinol; 2012 Jun; 26(6):955-66. PubMed ID: 22543272
[TBL] [Abstract][Full Text] [Related]
16. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis.
Belguise K; Sonenshein GE
J Clin Invest; 2007 Dec; 117(12):4009-21. PubMed ID: 18037997
[TBL] [Abstract][Full Text] [Related]
17. EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.
Zhang Y; Su H; Rahimi M; Tochihara R; Tang C
Int J Cancer; 2009 Nov; 125(9):2021-8. PubMed ID: 19588487
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.
Ramamoorthy S; Tufail R; Hokayem JE; Jorda M; Zhao W; Reis Z; Nawaz Z
Breast Cancer Res Treat; 2012 Feb; 132(1):97-108. PubMed ID: 21553290
[TBL] [Abstract][Full Text] [Related]
19. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-α signaling in post-natal mammary development and breast cancers.
Rusidzé M; Adlanmérini M; Chantalat E; Raymond-Letron I; Cayre S; Arnal JF; Deugnier MA; Lenfant F
Cell Mol Life Sci; 2021 Aug; 78(15):5681-5705. PubMed ID: 34156490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
